Mission Viejo, CA Mon–Fri 9–5 · Sat 9–1 Free consultation available — Book today
Fresh vegetables and a prepared salad bowl on a wooden table — semaglutide with diet and exercise at OC Weight Loss & Med
Photo: Maksim Goncharenok / Pexels

Semaglutide with Diet and Exercise: How to Get the Most from Your Treatment

Medically reviewed by the clinical team at OC Weight Loss & Med Spa · Last reviewed

Quick summary: Semaglutide (a GLP-1 receptor agonist) reduces appetite and slows gastric emptying, which helps create the calorie deficit needed for meaningful weight loss. Clinical trials in adults with obesity showed average body-weight reductions of roughly 15 percent over 68 weeks when the medication was combined with lifestyle changes. At OC Weight Loss & Med Spa, the medication is one part of a supervised program that also includes nutritional guidance and a movement plan tailored to your health history. Individual results vary.

What semaglutide is and how it works

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist administered as a once-weekly subcutaneous injection. It was originally approved for type 2 diabetes management and later approved at higher doses specifically for chronic weight management in adults with obesity or overweight with a related health condition.

The medication works through several mechanisms. It slows gastric emptying, which means food stays in the stomach longer and promotes a feeling of fullness after smaller meals. It also acts on appetite-regulating centers in the brain, reducing hunger signals. Together, these effects make it easier to maintain a lower calorie intake without constant hunger.

Dosing starts low and is titrated upward over several months to improve tolerability. A clinician supervises this process and adjusts the schedule based on how the patient responds.

Why lifestyle changes are still essential

Semaglutide reduces appetite, but it does not independently determine what you eat or how active you are. The largest clinical trials paired the medication with reduced-calorie dietary guidance and increased physical activity. Patients who engaged with both components consistently achieved greater and more durable results than medication alone.

The practical goal is to use the reduced hunger as a window to build sustainable habits — not simply to eat less of the same foods, but to shift toward a pattern your body can maintain after the treatment course.

Building an effective diet plan

Because semaglutide slows digestion, smaller, nutrient-dense meals tend to feel more comfortable than large ones. A few principles that pair well with the medication:

  • Prioritize protein at each meal (chicken, fish, eggs, legumes) to preserve lean muscle during weight loss.
  • Fill half the plate with non-starchy vegetables to add volume and fiber without a large calorie load.
  • Limit ultra-processed foods and sugary beverages, which can blunt the satiety signals the medication helps create.
  • Stay well-hydrated — adequate fluid intake supports digestion and can reduce some of the GI side effects that occasionally occur during dose escalation.

Our clinical team provides individualized nutritional guidance as part of the program. If you have a history of disordered eating or specific medical conditions, those factors are incorporated into the plan at your consultation.

Building an effective exercise plan

Physical activity supports weight loss through calorie expenditure and — critically for semaglutide patients — through muscle preservation. When weight loss is rapid, some of it can come from lean tissue. Resistance training helps minimize that loss.

A practical starting framework:

  • Aerobic activity: Aim for at least 150 minutes per week of moderate-intensity movement — brisk walking, cycling, swimming, or similar. This can be split into 30-minute sessions five days a week.
  • Resistance training: Two to three sessions per week targeting major muscle groups. Bodyweight exercises, resistance bands, or free weights all work. The goal is to maintain strength and metabolic rate as body weight decreases.
  • Consistency over intensity: Starting with manageable sessions and building gradually reduces injury risk and makes it easier to stay on schedule.

Some patients experience mild fatigue or nausea during dose escalation. On those days, lighter movement — a walk rather than a gym session — is appropriate. Communicate any exercise-related concerns with your provider so the dosing schedule can be adjusted if needed.

Safety, side effects, and who should not use semaglutide

Semaglutide is a prescription medication with a known side effect profile and specific contraindications. Candidacy is determined at a clinical consultation.

Common side effects are primarily gastrointestinal and most pronounced during the early dose-escalation phase:

  • Nausea (the most frequently reported side effect)
  • Vomiting or diarrhea
  • Constipation
  • Reduced appetite beyond what is desired (particularly early on)

These effects typically improve as the body adjusts to the medication. Eating smaller meals, avoiding high-fat foods around injection days, and staying hydrated can reduce their severity.

Boxed warning — thyroid C-cell tumors: In rodent studies, semaglutide caused thyroid C-cell tumors. It is not known whether this applies to humans, but semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Patients should report any neck lump, hoarseness, or difficulty swallowing to their provider.

Other contraindications and precautions:

  • Pregnancy or planned pregnancy — semaglutide should be discontinued at least two months before a planned pregnancy
  • History of pancreatitis — use with caution; discontinue if pancreatitis is suspected
  • Diabetic retinopathy — rapid improvement in blood glucose has been associated with worsening retinopathy in some patients
  • Severe renal impairment — requires clinical review
  • Hypersensitivity to semaglutide or any excipient

This list is not exhaustive. Your full medical history, current medications, and individual health profile are reviewed at consultation before any prescription is written.

What to expect from the program at OC Weight Loss & Med Spa

Our medical weight loss program in Mission Viejo is supervised by Dr. Nezar Dahdal, MD (board-certified, Internal Medicine) and delivered by Lindsay Short, NP, a board-certified Nurse Practitioner. Treatment begins with a thorough health assessment to confirm candidacy, establish baseline measurements, and set realistic goals.

Ongoing check-ins allow the clinical team to adjust dosing, troubleshoot side effects, and track progress. The program integrates the medication with dietary guidance and a movement plan appropriate to your current fitness level.

Financing options include Cherry, CareCredit, and Alle. The clinic is located at 24002 Via Fabricante #201, Mission Viejo, CA 92691. Office hours are Monday through Friday 9 am – 5 pm and Saturday 9 am – 1 pm. You can also reach us at reach us here or call (949) 416-0950.

Frequently asked questions

How much weight can I expect to lose on semaglutide?

In clinical trials, adults with obesity who used semaglutide alongside lifestyle intervention lost an average of approximately 15 percent of body weight over about 68 weeks. Individual results vary based on starting weight, adherence to dietary and activity guidance, dosing, and other health factors. Realistic goal-setting is part of the initial consultation.

Can I exercise normally while taking semaglutide?

Most patients can exercise as usual. During the early weeks of dose escalation, nausea or fatigue may reduce exercise capacity temporarily. Lighter activity — walking instead of high-intensity training — is reasonable on those days. If symptoms are persistent or severe, let your provider know so they can evaluate the dosing schedule.

How long do I need to take semaglutide?

Semaglutide for weight management is intended as a long-term treatment. Clinical data shows that weight tends to return when the medication is stopped without the accompanying lifestyle changes being firmly established. Duration of treatment is individualized and discussed as part of the ongoing clinical relationship.

Is semaglutide the same as Ozempic or Wegovy?

Yes — Ozempic and Wegovy both contain semaglutide as the active ingredient. Ozempic is FDA-approved for type 2 diabetes management; Wegovy is FDA-approved specifically for chronic weight management at a higher target dose. Your provider will discuss the appropriate formulation and dosing based on your health profile.

Who is a good candidate for semaglutide?

General clinical eligibility criteria include a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol. Candidacy also depends on the absence of the contraindications listed above and is confirmed through a medical evaluation.

Ready to learn whether semaglutide is right for you?

A free consultation with our clinical team in Mission Viejo is the first step. We review your health history, answer your questions, and determine whether semaglutide — or another approach — is the right fit for your goals. There is no obligation.

Book a free consultation

Related treatments at our Mission Viejo clinic

Not sure which treatment fits? These are the related services our clinicians most often discuss at a consultation.

References

  1. Once-Weekly Semaglutide in Adults with Overweight or Obesity — N Engl J Med 2021, via PubMed
  2. Pharmacological management of obesity: an endocrine Society clinical practice guideline — J Clin Endocrinol Metab 2015, via PubMed
Book a Free Consultation